FindTrial
Sign In

Ganglion Block for Post-dural Puncture Headache.

Transnasal sphenopalatine ganglion block for post-dural puncture headache of moderate severity : an observer blind, parallel group randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023754
Enrollment
70
Registered
2020-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Transnasal Sphenopalatine Ganglion Block: Patient supine with head in sniffing position. After visualy inspecting each nostril two long cotton tipped applicators soaked in 2% lidocaine

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All postpartum women aged 18-40 years who received Neuraxial anaesthesia for cesarean delivery and are diagnosed with a moderately severe post dural puncture headache within 48 hours post partum.

Exclusion criteria

Exclusion criteria: History of Migraines and chronic headache. Bleeding disorder. Gross deformity or infection of the nasal septum, nasal polyp, nasal or sines surgery within the past year. Chronic narcotic user. Neurological disorder. pregnancy induced hypertension. Allergy to local anaesthetics.

Design outcomes

Primary

MeasureTime frame
Relief of Post dural puncture headacheTimepoint: 30 minutes—

Secondary

MeasureTime frame
Adverse effect of DrugTimepoint: Immediate—

Countries

India

Contacts

Public ContactDr Sujata Ghosh

Institute of Post Graduate Medical Education and Research.

dr.sujata444@gmail.com9903663696

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026